Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 32, 2020 - Issue 13-14
2,304
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Particulate matter less than 10 μm (PM10) activates cancer related genes in lung epithelial cells

ORCID Icon, , , , , & show all
Pages 487-493 | Received 23 Aug 2020, Accepted 05 Nov 2020, Published online: 07 Dec 2020

References

  • Aklillu E, Øvrebø S, Botnen IV, Otter C, Ingelman-Sundberg M. 2005. Characterization of common CYP1B1 variants with different capacity for benzo[a]pyrene-7,8-dihydrodiol epoxide formation from benzo[a]pyrene. Cancer Res. 65:5105.
  • Anwar-Mohamed A, Elbekai RH, El-Kadi AO. 2009. Regulation of CYP1A1 by heavy metals and consequences for drug metabolism. Expert Opin Drug Metab Toxicol. 5:501–521.
  • Atkinson RW, Fuller GW, Anderson HR, Harrison RM, Armstrong B. 2010. Urban ambient particle metrics and health: a time-series analysis. Epidemiology. 21:501–511.
  • Bhan A, Soleimani M, Mandal SS. 2017. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 77:3965–3981.
  • Bingle CD, Bingle L. 2000. Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta. 1493:363–367.
  • Bingle CD, Craven CJ. 2002. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet. 11:937–943.
  • Bingle CD, Bingle L, Craven CJ. 2011. Distant cousins: genomic and sequence diversity within the BPI fold-containing (BPIF)/PLUNC protein family. Biochem Soc Trans. 39:961–965.
  • Brown JS, Gordon T, Price O, Asgharian B. 2013. Thoracic and respirable particle definitions for human health risk assessment. Part Fibre Toxicol. 10:12.
  • Cadelis G, Tourres R, Molinie J. 2014. Short-term effects of the particulate pollutants contained in Saharan dust on the visits of children to the emergency department due to asthmatic conditions in Guadeloupe (French Archipelago of the Caribbean). PLoS One. 9:e91136.
  • Chang J, Go YY, Park MK, Chae SW, Lee SH, Song JJ. 2016. Asian sand dust enhances the inflammatory response and mucin gene expression in the middle ear. Clin Exp Otorhinolaryngol. 9:198–205.
  • Choi H, Shin DW, Kim W, Doh SJ, Lee SH, Noh M. 2011. Asian dust storm particles induce a broad toxicological transcriptional program in human epidermal keratinocytes. Toxicol Lett. 200:92–99.
  • Ding X, Wang M, Chu H, Chu M, Na T, Wen Y, Wu D, Han B, Bai Z, Chen W, et al. 2014. Global gene expression profiling of human bronchial epithelial cells exposed to airborne fine particulate matter collected from Wuhan. Toxicol Lett. 228:25–33.
  • Downs SH, Schindler C, Liu LJS, Keidel D, Bayer-Oglesby L, Brutsche MH, Gerbase MW, Keller R, Künzli N, Leuenberger P, et al.; SAPALDIA Team. 2007. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med. 357:2338–2347.
  • Gajjar K, Martin-Hirsch PL, Martin FL. 2012. CYP1B1 and hormone-induced cancer. Cancer Lett. 324:13–30.
  • Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. 2013. Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med. 187:721–727.
  • Geetha C, Venkatesh SG, Dunn BHF, Gorr SU. 2003. Expression and anti-bacterial activity of human parotid secretory protein (PSP). Biochem Soc Trans. 31:815–818.
  • Gerlofs-Nijland ME, Dormans JAMA, Bloemen HJT, Leseman DLAC, Boere AJF, Kelly FJ, Mudway IS, Jimenez AA, Donaldson K, Guastadisegni C, et al. 2007. Toxicity of coarse and fine particulate matter from sites with contrasting traffic profiles. Inhalation Toxicol. 19:1055–1069.
  • Gorr SU, Abdolhosseini M, Shelar A, Sotsky J. 2011. Dual host-defence functions of SPLUNC2/PSP and synthetic peptides derived from the protein. Biochem Soc Trans. 39:1028–1032.
  • Guaita R, Pichiule M, Maté T, Linares C, Díaz J. 2011. Short-term impact of particulate matter (PM2.5) on respiratory mortality in Madrid. Int J Environ Health Res. 21:260–274.
  • Gualtieri M, Longhin E, Mattioli M, Mantecca P, Tinaglia V, Mangano E, Proverbio MC, Bestetti G, Camatini M, Battaglia C, et al. 2012. Gene expression profiling of A549 cells exposed to Milan PM2.5. Toxicol Lett. 209:136–145.
  • Guarnieri M, Balmes JR. 2014. Outdoor air pollution and asthma. Lancet. 383:1581–1592.
  • Halonen JI, Lanki T, Yli-Tuomi T, Tiittanen P, Kulmala M, Pekkanen J. et al. 2009. Particulate air pollution and acute cardiorespiratory hospital admissions and mortality among the elderly. Epidemiology. 20:143–153.
  • IARC. 2013. Air pollution and cancer. [accessed 2020 May 6]. http://www.iarc.fr/en/publications/books/sp161/AirPollutionandCancer161.pdf
  • Ji YN, Wang Q, Suo LJ. 2012. CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis. PLOS One. 7:e43397.
  • Korashy HM, El-Kadi AOS. 2005. Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals. Toxicol Sci. 88:39–51.
  • Lee KY, Batmunkh T, Joo HS, Park K. 2018. Comparison of the physical and chemical characteristics of fine road dust at different urban sites. J Air Waste Manag Assoc. 68:812–823.
  • Ministry of Environment. 2016. What is the particulate matter? [accessed 2020 May 6]. http://me.go.kr/home/file/readDownloadFile2.do?fileId=127372&fileSeq=1&fileName=968ea7e08690ebc49b8d6fc4acec5fe7a65f35aee9723b5e33bd822a90cfe874294e029bed96e3250c0b2727ef682584c50c83635c79eed6166b8be5e6af1223&openYn=Y
  • Mollerup S, Berge G, Baera R, Skaug V, Hewer A, Phillips DH, Stangeland L, Haugen A. 2006. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer. 119:741–744.
  • OECD. 2016. The Economic Consequences of Outdoor Air Pollution. [accessed 2020 May 6]. https://www.oecd-ilibrary.org/content/publication/9789264257474-en
  • Perez L, Tobías A, Querol X, Pey J, Alastuey A, Díaz J, Sunyer J. 2012. Saharan dust, particulate matter and cause-specific mortality: A case–crossover study in Barcelona (Spain). Environ Int. 48:150–155.
  • Pope III CA. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 287:1132–1141.
  • Prokopovic V, Popovic M, Andjelkovic U, Marsavelski A, Raskovic B, Gavrovic-Jankulovic M, Polovic N. 2014. Isolation, biochemical characterization and anti-bacterial activity of BPIFA2 protein. Arch Oral Biol. 59:302–309.
  • Przygodzki R, Bennett WP, Guinee DG Jr, Khan MA, Freedman A, Shields PG, Travis WD, Jett JR, Tazelaar H, Pairolero P, et al. 1998. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. Pharmacogenetics. 8:503–511.
  • Raaschou-Nielsen O, Andersen ZJ, Beelen R, Samoli E, Stafoggia M, Weinmayr G, Hoffmann B, Fischer P, Nieuwenhuijsen MJ, Brunekreef B, et al. 2013. Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol. 14:813–822.
  • Sawrycki P, Domagalski K, Cechowska M, Gąsior M, Jarkiewicz-Tretyn J, Tretyn A. 2018. Relationship between CYP1B1 polymorphisms (c.142C > G, c.355G > T, c.1294C > G) and lung cancer risk in Polish smokers. Future Oncol. 14:1569–1577.
  • Sharma AK, Jensen KA, Rank J, White PA, Lundstedt S, Gagne R, Jacobsen NR, Kristiansen J, Vogel U, Wallin H, et al. 2007. Genotoxicity, inflammation and physico-chemical properties of fine particle samples from an incineration energy plant and urban air. Mutat Res. 633:95–111.
  • Shimada T, Fujii-Kuriyama Y. 2004. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and1B1. Cancer Sci. 95:1–6.
  • Sissung TM, Price DK, Sparreboom A, Figg WD. 2006. Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol Cancer Res. 4:135–150.
  • Sun H, Shamy M, Kluz T, Muñoz AB, Zhong M, Laulicht F, Alghamdi MA, Khoder MI, Chen LC, Costa M, et al. 2012. Gene expression profiling and pathway analysis of human bronchial epithelial cells exposed to airborne particulate matter collected from Saudi Arabia. Toxicol Appl Pharmacol. 265:147–157.
  • Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, et al. 2003. Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol. 32:60–63.
  • Tecer LH, Alagha O, Karaca F, Tuncel G, Eldes N. 2008. Particulate matter (PM2.5, PM10-2.5, and PM10) and children’s hospital admissions for asthma and respiratory diseases: a bidirectional case-crossover study. J Toxicol Environ Health A. 71:512–520.
  • Thomson S, Petti F, Sujka-Kwok I, Epstein D, Haley JD. 2008. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy. Clin Exp Metastasis. 25:843–854.
  • Thurston GD, Kipen H, Annesi-Maesano I, Balmes J, Brook RD, Cromar K, De Matteis S, Forastiere F, Forsberg B, Frampton MW, et al. 2017. A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework. Eur Respir J. 49:1600419.
  • Uppstad H, Øvrebø S, Haugen A, Mollerup S. 2010. Importance of CYP1A1 and CYP1B1 in bioactivation of benzo[a]pyrene in human lung cell lines. Toxicol Lett. 192:221–228.
  • Wapinski O, Chang HY. 2011. Long noncoding RNAs and human disease. Trends Cell Biol. 21:354–361.
  • Wendling Z, Emerson J, Esty D, Levy M, de Sherbinin A. et al. 2018. 2018 Environmental Performance Index (EPI).
  • WHO. 2013. Health effects of particulate matter. Policy implications for countries in Eastern Europe, Caucasus and central Asia. [accessed 2020 May 6]. http://www.euro.who.int/__data/assets/pdf_file/0006/189051/Health-effects-of-particulate-matter-final-Eng.pdf?ua=1
  • Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, et al. 2015. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell. 28:529–540.